1. Home
  2. CVV vs HBIO Comparison

CVV vs HBIO Comparison

Compare CVV & HBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CVD Equipment Corporation

CVV

CVD Equipment Corporation

N/A

Current Price

$3.83

Market Cap

27.9M

Sector

Technology

ML Signal

N/A

Logo Harvard Bioscience Inc.

HBIO

Harvard Bioscience Inc.

N/A

Current Price

$8.86

Market Cap

26.5M

Sector

Industrials

ML Signal

N/A

Company Overview

Basic Information
Metric
CVV
HBIO
Founded
1982
1901
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Laboratory Analytical Instruments
Sector
Technology
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
27.9M
26.5M
IPO Year
2007
2000

Fundamental Metrics

Financial Performance
Metric
CVV
HBIO
Price
$3.83
$8.86
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
★ 48.0K
14.8K
Earning Date
11-09-2026
11-10-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 17.86
N/A
EPS
★ 1.58
N/A
Revenue
$41,128,639.00
★ $116,176,000.00
Revenue This Year
N/A
$3.76
Revenue Next Year
N/A
$5.29
P/E Ratio
$2.55
★ N/A
Revenue Growth
★ 96.27
N/A
52 Week Low
$2.96
$0.40
52 Week High
$9.10
$9.00

Technical Indicators

Market Signals
Indicator
CVV
HBIO
Relative Strength Index (RSI) 35.78 68.10
Support Level $3.74 $7.90
Resistance Level $4.44 N/A
Average True Range (ATR) 0.20 0.31
MACD 0.09 0.03
Stochastic Oscillator 36.90 87.28

Price Performance

Historical Comparison
CVV
HBIO

About CVV CVD Equipment Corporation

CVD Equipment Corp designs, develops, and manufactures a broad range of equipment used to develop and produce materials and coatings for the aerospace, compound semiconductor, semiconductor, aerospace, battery energy storage markets as well as industrial applications, and research. It currently conducts its business through two reportable segments: CVD Equipment, which designs and manufactures chemical vapor deposition, physical vapor transport and thermal process equipment; and SDC, which designs and manufactures ultra-high purity gas and chemical delivery control systems. Its target markets are aerospace & defense and industrial, microelectronics / high power electronics, and EV battery materials / energy storage.

About HBIO Harvard Bioscience Inc.

Harvard Bioscience Inc is a developer, manufacturer, and seller of technologies, products, and services that enable advances in life science applications, including research, drug and therapy discovery, bioproduction, and preclinical testing. The company organizes its product line into two product families: Cellular and Molecular Technologies (CMT) and Preclinical. The CMT product family supports molecular, cellular, organ, and organoid research, as well as bioproduction and in vitro testing, while the Preclinical product family provides products for preclinical research and testing, including data collection and analysis for safety and regulatory compliance. Its geographical segments include the Americas, Europe, Middle East and Africa, and Asia.

Share on Social Networks: